Status in the House for the 93rd Legislature (2023 - 2024)
Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
House Actions | |
---|---|
02/13/2024 | |
Introduction and first reading, referred to Health Finance and Policy
|
|
02/26/2024 | |
Author added Reyer
pg.
11475
|
|
03/13/2024 | |
Author added Nadeau
pg.
11852
|
|
03/18/2024 | |
Author added Hemmingsen-Jaeger
pg.
12002
|